{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:22:53Z","timestamp":1789053773572,"version":"build-2803163510"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2601413","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:47:31Z","timestamp":1767628051000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study"],"prefix":"10.1080","volume":"21","author":[{"given":"Sandra","family":"Villagomez-Martinez","sequence":"first","affiliation":[{"name":"Centro de Investigaci\u00f3n-Instituto Nacional de Pediatr\u00eda","place":["Morelos, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kharit","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cChildren\u2019s Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency,\u201d","place":["St. Petersburg, Russian Federation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galustyan","sequence":"additional","affiliation":[{"name":"LLC \u201cMedical Technologies,\u201d and Saint Petersburg Pediatric Medical University","place":["St. Petersburg, Russian Federation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betzana","family":"Zambrano","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Montevideo, Uruguay"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Singh Dhingra","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Swiftwater, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"B\u2019Chir","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy-l\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Syrkina","sequence":"additional","affiliation":[{"name":"Sanofi R&D","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9615-0123","authenticated-orcid":false,"given":"Olga","family":"Lyabis","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Marcy L\u2019\u00c9toile, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rehm","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Swiftwater, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"e_1_3_5_2_1","first-page":"619","volume-title":"Plotkin\u2019s vaccines","author":"Plotkin SA","year":"2018","unstructured":"Plotkin SA, Orenstein WA, Offit PA, Edwards KM, Harrison LH, Granoff D, Pollard AJ. Meningococcal capsular group A, C, W, and Y conjugate vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, Harrison LH, Granoff D, Pollard AJ, editors.Plotkin\u2019s vaccines. 7th ed. Philadelphia: Elsevier; 2018. p. 619\u2013643.e11.","edition":"7"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000328"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101521"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(06)67932-4"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"e_1_3_5_9_1","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological reports (AERs). [accessed 2025 Oct 17]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/monitoring\/all-annual-epidemiological-reports."},{"key":"e_1_3_5_10_1","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease - annual epidemiological report for 2022. 2024 [accessed 2025 Oct 17]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2022."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.05.006"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1258308"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.23937\/2474-3658\/1510086"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.10.022"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.21767\/2472-1093.100031"},{"key":"e_1_3_5_16_1","unstructured":"WHO. Invasive meningococcal disease reported cases and incidence. [accessed 2025 Oct 17]. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/invasive-meningococcal-disease-reported-cases-and-incidence?CODE=MEX&YEAR=."},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.31631\/2073-3046-2023-22-4-67-74"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.31631\/2073-3046-2024-23-5-33-41"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.35627\/2022-30-12-73-80"},{"key":"e_1_3_5_20_1","unstructured":"Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. The epidemiological situation with meningococcal infection in the Russian Federation is stable. 2025 July 16 [accessed 2025 Oct 17]. https:\/\/www.rospotrebnadzor.ru\/about\/info\/news\/news_details.php?ELEMENT_ID=30409."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1733"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1451287"},{"key":"e_1_3_5_23_1","unstructured":"WHO. Essential programme on immunization. [accessed 2025 Oct 17]. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/essential-programme-on-immunization\/."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1091908"},{"key":"e_1_3_5_25_1","unstructured":"U.S. Food and Drug Administration. Approval letter for MenQuadfi. 2025 May 23 [accessed 2025 Oct 17]. https:\/\/www.fda.gov\/media\/186697\/download."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268821000261"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1964962"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1733869"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268821000698"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000002832"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.03.017"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.06.013"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1733868"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.067"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01009-x"},{"key":"e_1_3_5_36_1","unstructured":"MenQuadfi\u00ae summary of product characteristics. 2024 [accessed 2025 Oct 17]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/menquadfi-epar-product-information_en.pdf."},{"key":"e_1_3_5_37_1","unstructured":"ClinicalTrials.gov. Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in the US. [accessed 2024 Oct 15]. https:\/\/clinicaltrials.gov\/study\/NCT03537508."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27051"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31823dce5c"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.01.050"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-018-1440-z"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.31631\/2073-3046-2019-18-3-28-39"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-0254-1"},{"key":"e_1_3_5_45_1","unstructured":"Central Research Institute of Epidemiology of Rospotrebnadzor of the Russian Federation. Meningococcal disease and bacterial purulent meningitis in the Russian Federation 2023. Information and Analytical Review; 2024."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2601413","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2601413","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2601413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:38:55Z","timestamp":1786034335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2601413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2601413"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2601413","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2601413"}}